Neubauer calls for the return of the 30-year Treasury

Nickolas Neubauer, chairman of the Chicago Board of Trade (CBOT) futures market, has called on the US Treasury to return to issuing 30-year bonds. The issuing of more long-term debt is likely to boost trading in the CBOT’s 30-year US Treasury bond future.

Neubauer, speaking on US television, said that given the current economic conditions and President Bush’s recently announced fiscal stimulus package, the 30-year bond will be needed for future US financing. “The problem I see is that post-2010, we’re going to have huge financing, and that’s why I think we should start putting away 30-year money right now,” said Neubauer.

“Back when we had surpluses, that’s when it [the 30-year bond] was ended. Now we’ve swung to substantial deficits," he added. "Plus we have a substantial stimulus programme. And even before all that, post-2010, everyone agreed we were going to have large deficits again, because of the baby boomers now collecting social security.”

The CBOT introduced its 30-year Treasury bond future in 1977, when the US treasury was primarily issuing 30-year debt. The contract subsequently became the exchange's most highly traded contract. Today, however, the 10-year contract is the benchmark.

Neubauer said he was happy with Bush’s plan to stimulate the US economy. “I think the fact that the stimulus programme has edged up from $200 billion to $674 billion does make it a major factor in how we look at deficits over the coming years… that creates interest in our markets, and volatility.”

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here